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Abstract 
Background: Early after intubation, a layer of biofilm covers the inner lumen of the endotracheal tube (ETT). Clean-
ing the ETT might prevent airways colonization by pathogens, reduce resistance to airflow, and decrease sudden ETT 
obstruction. We investigated the effectiveness of a cleaning closed suction system in maintaining the endotracheal 
tube free from secretions.
Methods: We conducted a single center, randomized controlled trial, in the general intensive care unit of a tertiary-
level university hospital. We enrolled 40 adult critically ill patients expected to remain intubated for more than 48 h, 
within 24 h from intubation. Patients were randomized to receive three ETT cleaning maneuvers/day using a novel 
device (Airway Medix Closed Suction System™, cleaning group) or to standard care (no ETT cleaning, standard closed 
suction, control group). After extubation, the amount of secretions in the ETTs was measured by micro-computed 
tomography.
Results: The volume of secretions in the ETTs from the cleaning group was lower than controls (0.081 [0.021–0.306] 
vs. 0.568 [0.162–0.756] mL, p = 0.001), corresponding to a cross-sectional area reduction six times lower (1[0–3] vs. 6 
[2–10] %, p = 0.001). In a subset of 16 patients, the resistance to airflow tended to be lower after 1 day of treatment 
(p = 0.063) and was lower after 2 days (0.024), while no difference was present at enrollment (p = 0.922). ETT coloni-
zation did not differ between the two groups.
Conclusions: The use of a novel cleaning closed suction system proved to be effective in reducing secretions pre-
sent in the ETT after extubation, possibly reducing resistance to airflow during intubation.
Trial registration: clinicaltrials.gov NCT01912105
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Background
Endotracheal intubation is a necessary choice to ven-
tilate many critically ill patients; however, the use of 
an endotracheal tube (ETT) is associated with several 
complications [1]. The presence of secretions within the 
ETT has been advocated in the pathogenesis of ventila-
tor-associated pneumonia (VAP) since many years [2]. 
Soon after intubation, in the ETT is detectable a layer of 
biofilm composed by mucosal secretions, erythrocytes, 
neutrophils, and possibly microbes [3]. The ETT biofilm 
thickness increases with time and airflow can transport 
microbial aggregates towards the distal airways, leading 
to pneumonia [4]. The link between ETT biofilm and 
VAP has been well established: the prevention of bio-
film formation or its removal through modified ETTs 
has been associated with reduced incidence of VAP in 
the clinical scenario [5]. Standard care is not adequate to 
completely remove secretions from the ETT and several 
additional measures aimed to reduce ETT biofilm have 
been proposed to prevent VAP [6].
The presence of secretions within the ETT is also 
potentially associated with obstruction and increased 
resistance to airflow. Specifically designed devices (i.e., 
the Mucus Shaver) are able to mechanically remove 
secretions from the inner ETT surface, maintaining ETT 
patency and reducing ETT bacterial colonization [7]. In 
difficult to wean patients, restoring airway resistance to 
nominal values through ETT secretion removal might 
represent a clinically relevant advantage.
In this randomized trial, we evaluated the efficacy of a 
cleaning closed suction system (CSS), a device designed 
to combine a closed suction catheter and an ETT water-
based cleaning system. The device is designed to be used 
several times for all the duration of intubation, with the 
aim of keeping the ETT free from secretions and there-
fore the potential advantage of lower ETT microbial colo-
nization and lower resistance to airflow. We hypothesized 
that patients treated with the cleaning CSS would have, at 
the moment of extubation, a lower amount of secretions 
within the ETT as compared to controls treated with a 
standard CSS. We measured the volume of secretions 
present in the ETT after extubation using Micro-com-
puted tomography (MicroCT), a reliable technique able 
to measure the amount of secretions of a large part of the 
ETT [8].
Methods
Ethics, consent, and permissions
We conducted a controlled randomized single-blinded 
clinical trial (clinicaltrials.gov: NCT01912105) in the gen-
eral intensive care unit (ICU) of a tertiary-care university 
hospital (San Gerardo Hospital, Monza, Italy). The study 
was approved by the local Institutional Review Board 
(San Gerardo Hospital Ethical Committee) and was car-
ried out in compliance with the Helsinki Declaration. 
Request of written informed consent was delayed until 
patient recovery and family members were informed, as 
per local regulation.
Patients
From April 2013 to June 2014, forty patients were rand-
omized and successfully completed the study (see Fig. 1). 
Inclusion criteria were as follows: age  >18  years old, 
intubation within 24 h, expected intubation longer than 
48 h, and FiO2 <80 % at the moment of patients screen-
ing. Exclusion criteria were as follows: current or past 
participation in another intervention trial conflicting 
with the present study, expected survival less than 24 h or 
high probability of unfavorable outcome (e.g., return of 
spontaneous circulation after unwitnessed cardiac arrest, 
no-flow >10 min or age >65), acute severe asthma, extra-
corporeal membrane oxygenation treatment, presence 
of double lumen ETT, known difficult airway manage-
ment in case of ETT displacement (such as upper airway 
edema, or cervical spine trauma), and contraindication 
posed by staff physicians. Patients enrolled in the study 
who were extubated and required reintubation were not 
enrolled in the study a second time.
Study protocol
Upon enrollment, patients were randomized to receive 
standard care (control group) with the CSS in use in our 
ICU (KimVent closed suction system, Kimberly-Clark 
Corp., Neenah, WI USA,) or the use of a novel clean-
ing CSS (Airway Medix closed suctioning system, Biovo 
Assessed for eligibility (n=413)
Excluded  (n=373 )
- Not meeting inclusion criteria (n=356)
- Meeting exclusion criteria (n=16)
expected unfavorable outcome (n=4)
acute severe asthma (n=2)
ECMO (n=8)
difficult airways (n=2)
- Declined to participate (n=1 )
Randomized (n=40)
Allocated and treated with
Standard CSS (n=20)
Allocated and treated with
Cleaning CSS (n=20)
Completed the study and 
included in analysis (n=20)
Completed the study and 
included in analysis (n=20)
Fig. 1 The CONSORT diagram for the study procedures. A total of 
40 patients were randomized to receive ETT cleaning (treatment 
group) or standard care (controls). ECMO extracorporeal membrane 
oxygenation; CSS closed suction system
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Technologies, Tel Aviv, Israel, treatment group). A com-
puter-based random sequence was used to obtain a 1:1 
randomization ratio in blocks of 10 patients. The clean-
ing CSS used in the treatment group is a suction cathe-
ter with aspiration holes on the side and a balloon on its 
tip, which normally remains deflated and can be used to 
perform a standard suction maneuver. When the clean-
ing option is activated, the same device can also be used 
to clean the ETT: the catheter is inserted within the ETT 
similarly to a standard suction maneuver, and then the 
activation of the suction channel occurs together with 
the inflation of the cleaning balloon and the activation 
of water jets. When the catheter is gently retracted, the 
inflated balloon and the water jets gather secretions 
from the ETT wall, which are removed by the aspirating 
system.
A standard CSS was used in the control group, while 
in the treatment group tracheal suction was performed 
with the study CSS with the cleaning option disabled. In 
the treatment group, three additional cleaning maneu-
vers were performed every day (once every shift). Tra-
cheal suction maneuvers were performed by critical care 
nurses when needed, based on the standard protocol in 
use in our ICU with the aim of a secretion detector [9], 
both in the treatment and in the control groups. Further 
details about airways management can be found in the 
supplemental digital content (Additional file 1).
Data collection
Patient’s history and demographics were recorded, 
together with several clinical parameters, investigating 
the presence of Acute Respiratory Distress Syndrome 
diagnosis [10] and assessing the Simplified Acute Physi-
ology Score II [SAPS2] [11].
We collected daily clinical data regarding ventilator 
parameters and signs of infection, to calculate a modi-
fied clinical pulmonary infection score (mCPIS) [12]. 
Nurses recorded the total number of tracheal suc-
tion maneuvers performed, along with major adverse 
events related to the use of the new cleaning device. 
These were defined as follows: desaturation (drop in 
SpO2  >5  %) persisting for more than 5  min after suc-
tion and requiring a change in ventilator parameters; 
modification of blood pressure (systolic  >200  mmHg 
or diastolic  <80  mmHg if not already present) requir-
ing new drug therapy; persistent reduction of ETCO2 
(drop  >5  mmHg); persistence of tachycardia or occur-
rence of other arrhythmia following the cleaning 
maneuver; ETT displacement requiring reintubation. 
When planned in advance, we collected surveillance 
tracheal aspirate samples in the 24 h prior to extubation. 
At extubation, we recorded ICU length of stay, ventila-
tor free days in the first 28 days, and patient outcome. 
We also assessed the incidence of VAP and ventilator-
associated events (VAE). Further details about data col-
lection are provided in the Additional file 1.
Sample processing
After extubation, an investigator blind to the randomiza-
tion group performed a MicroCT scan of the collected 
ETTs (SkyScan 1176, Bruker, Belgium) for a length of 
20  cm from the ETT tip. After image reconstruction, 
an automated software (CT Analyzer, Bruker, Belgium) 
analyzed the CT images based on densitometric criteria, 
to obtain the measurement of the total volume of secre-
tions and the ETT lumen cross-sectional area reduction 
due to the presence of secretions. Image analyses were 
conducted using the MicroCT scan embedded software 
(CT Analyzer, Bruker, Belgium). To describe the local 
distribution of the secretions within the ETT, we calcu-
lated the average amount of secretions and cross-sec-
tional area reduction every 0.5 mm. To analyze possible 
differences of the regional distribution of the secretions 
between the two groups, the same variables were also 
calculated dividing the ETT length in three equal parts: 
ventilator side, central, and tip side. After MicroCT scan, 
ETT microbial colonization was assessed (see Additional 
file 1 for details).
Statistical methods
We based our sample size estimation on previous explor-
ative laboratory analyses (unpublished data) investigating 
the volume of secretions present within ETTs after extu-
bation by CT scan. We hypothesized an average secre-
tions volume of 2.1 ±  2.1  ml in the control group, and 
0.2  ml in the treatment group. Therefore, a sample size 
of 20 patients per arm (total 40 enrolled patients) would 
provide 80 % power to detect a difference considering a p 
value level of 0.05 as significant.
Normality of variables’ distribution was assessed by 
Shapiro–Wilk’s test; normally and non-normally dis-
tributed data are presented as mean ±  SD and median 
[inter-quartile range], respectively. Differences between 
the two groups were tested by Student’s t-test for nor-
mally distributed variables, and by Mann–Whitney test 
for non-normally distributed variables. Categorical vari-
ables’ differences were analyzed by Fisher’s exact test in 
case of dichotomous variables, otherwise by Chi-Square 
test. To evaluate differences of secretion distribution 
within the ETT, a Repeated Measures ANOVA model 
was performed, considering the randomization group 
as between-subject factor, and the regional distribu-
tion (three ETT parts) as within-subject factor; Tukey’s 
correction for post hoc tests was used. Statistical analy-
ses were performed using SPSS software version 18.0 
(Chicago, IL) and SigmaPlot 11 (Systat software Inc., 
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Germany). A p value  <0.05 was considered statistically 
significant.
Results
Forty patients were studied; 26 were successfully extu-
bated, 12 died and ETTs were removed post-mortem, 
one had an unplanned extubation, one had a failed extu-
bation and required reintubation, and none underwent 
tracheostomy. In total, we collected data on 252 ventila-
tor days; nearly a thousand of tracheal suction maneuvers 
and more than 300 cleaning maneuvers were performed 
during the study. The nurses in charge of the patients did 
not report any relevant adverse event related to the use 
of the cleaning CSS, neither reported any major issue 
that prevented the correct use of the device. Sudden ETT 
occlusion requiring emergent bronchoscopy occurred 
in one patient in the treatment group and one patient in 
the control group; in both cases, after bronchoscopy, the 
ETTs were removed and the patients were re-intubated.
The control and the treatment groups were similar at 
enrollment, although patients in the treatment group 
tended to be more severe as showed by SAPS2 on admis-
sion (Table 1).
Secretions within the ETT
The volume of secretions present in the ETT at extuba-
tion was reduced in the treatment group, as compared to 
controls (p = 0.001, Table 2). Correspondingly, the ETT 
cross-sectional area occupied by secretions was six times 
lower in the treatment group, as compared to controls (p 
= 0.001, Table 2). Secretions amount in the control group 
increased from the ventilator to the tip side, while in the 
treatment group the regional distribution of secretions 
along the ETT was different, resulting lower and fairly 
constant along the entire ETT (p  < 0.001 for treatment 
effect, p  =  0.005 for the interaction between the treat-
ment effect and the region effect by ANOVA, see Fig. 2a 
for post hoc tests). 
Table 1 Baseline characteristics of the study population
BMI body mass index, SAPS2 Simplified acute physiology score II, PEEP positive end-expiratory pressure, ETT endotracheal tube, ID internal diameter, ARDS acute 
respiratory distress syndrome
a Measured at intubation
All patients, n = 40 Control group, n = 20 Treatment group, n = 20 P value
Age, years 69 (51–76) 67 (53–75) 73 (49–77) 0.892
Female sex, n (%) 15 (38) 7 (35) 8 (40) 1.0
BMI 26 (24–28) 27 (24–29) 24 (23–26) 0.100
SAPS2 51 ± 16 47 ± 16 56 ± 14 0.055
PaO2/FiO2
a 228 ± 94 214 ± 90 241 ± 99 0.375
PEEPa, cmH2O 10 (8–10) 10 (8–12) 9 (8–10) 0.104
Reason for admission, n (%) 0.112
 Medical 28 (70) 11 (55) 17 (85)
 Elective surgery 5 (12) 4 (20) 1 (5)
 Emergency surgery 7 (18) 5 (25) 2 (10)
ETT size, mm ID 7.5 (7.5–7.5) 7.5 (7.5–8.0) 7.5 (7.5–7.5) 0.113
Suspect of pneumonia, n (%) 13 (32) 6 (30) 7 (35) 1.0
ARDS diagnosis, n (%) 6 (15) 5 (25) 1 (5) 0.182
Table 2 ETT analysis after extubation
ETT endotracheal tube, CSA cross-sectional area, CFU colony forming units, n. pos. number of ETT lavage samples positive for leukocytes presence
All patients, n = 40 Control group, n = 20 Treatment group, n = 20 P value
Study ETT in place, days 5 (3–8) 5 (3–7) 5 (3–10) 0.512
ETT secretions, volume (mL) 0.274 (0.046–0.576) 0.568 (0.162–0.756) 0.081 (0.021–0.306) 0.001
Average CSA reduction  (%) 3 (1–6) 6 (2–10) 1 (0–3) 0.001
Tracheal aspirate cultures, log (CFU) 0 (0–5) 0 (0–3) 0 (0–5) 0.234
ETT colonization, log (CFU) 2 (0–4) 2 (0–4) 1 (0–4) 0.568
Leukocytes in ETT lavage, n. pos. (%) 6 (15) 6 (30) 0 (0) 0.019
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Analyzing the local cross-sectional area reduction in 
ETT slices of 0.5-mm thickness, the peak average lumen 
reduction was lower in the treatment than in the control 
group (3 ± 4.4 vs. 9.5 ± 8 %, p = 0.003, Fig. 2b). Con-
sidering the maximum local cross-sectional area reduc-
tion, none of the ETTs in the treatment group showed 
a lumen reduction over 20 % (maximum cross-sectional 
area reduction 17  %) at the moment of ETT removal. 
Instead, half of the patients in the control group had 
their ETTs showing a maximum cross-sectional area 
reduction of more than 20 % of the nominal value (maxi-
mum 34  %, p  <  0.001 for a cut-off of 20  % maximum 
cross-sectional area reduction in comparison with treat-
ment group).
Microbiological data
The total microbial growth of cultures obtained from the 
ETT lavages after extubation did not differ between the 
treatment and the control group, suggesting similar ETT 
colonization. Similarly, total microbial growth did not 
differ between the two groups considering the tracheal 
aspirate samples collected before extubation. However, 
leukocytes were present only in the ETT lavages of the 
control group (Table 2).
The VAP rate did not differ between the two groups 
(one VAP diagnosed in each group), as well as VAE ret-
rospectively assessed. We recorded 4 vs. 1 VAC, 3 vs. 1 
IVAC, 0 vs. 1 pVAP in the treatment and control group, 
respectively (all p > 0.05).
Clinical data during ICU stay
Mortality at ICU discharge did not differ between the 
treatment and the control group, as well as ventilator free 
days evaluated after 28 days from admission and length 
of ICU stay among survivors (Additional file  1 Table  1, 
reporting patients’ outcomes on study completion). Sev-
eral clinical variables related to lungs function and infec-
tion (such as PaO2/FiO2 ratio, mCPIS, see Table  3) did 
not differ between the two groups.
During ICU stay, the need of suctioning (median daily 
suction maneuvers after enrollment) tended to be lower 
in the treatment group as compared to controls (3 [2–
4] vs. 5 [3–7], p =  0.068), while we recorded no differ-
ence between the two groups at enrollment (3 [1–4] vs. 
3 [2–6], p = 0.463). The number of patients with one or 
more recordings of macroscopic presence of blood in 
the tracheal aspirates tended to be lower in the treat-
ment than in the control group (2/20 vs. 7/20, p = 0.058 
by Chi-square test). In the subset of patients (8 treat-
ments and 8 controls) ventilated in controlled modes for 
at least 24 h, we measured airways resistance daily, until 
switch to assisted modes of ventilation. Considering the 
first 3  days of ICU stay after enrollment, resistance to 
airflow during intubation tended to be lower in the treat-
ment group as compared to controls on day 1 (p = 0.063, 
Table  3), was lower on day  2 (0.024), and did not differ 
on day 3 (p = 0.317), while no difference was present at 
enrollment (p = 0.922). As in the general study popula-
tion, the ETT size did not differ between the two groups 
in this subset of patients (p = 0.798).
Discussion
In this randomized clinical trial, we showed that the 
regular use of a cleaning CSS is effective to reduce the 
volume of secretions present in the ETT at extuba-
tion, as assessed by MicroCT scan. We evaluated the 
effectiveness of a novel device in the everyday practice 
of a general ICU, excluding patients whose risk of ETT 
a
b
Fig. 2 Efficacy of the ETT cleaning system. a The volume of ETT 
secretions increases in the control group (black columns) from the 
ventilator to the tip side (secretions analyzed dividing the studied ETT 
length in three equal parts), while it is lower (p < 0.001 by ANOVA) 
and fairly constant in the treatment group (white columns). b ETT 
cross-sectional area reduction measured every 5 mm among treat-
ments (white circles) and controls (black circles). The maximum cross-
sectional area reduction is markedly lower in the treatment group 
(dashed lines, p = 0.003). *p < 0.05 as compared to controls
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displacement was too high for safety reasons, since we 
had no previous data available about the clinical use of 
the cleaning device. The presented data suggest that no 
specific limitation should be present for the use of such 
a cleaning CSS. We chose the volume of secretion pre-
sent at extubation as the primary endpoint because the 
device was primarily designed to remove secretions, 
either by aspiration or cleaning. We reasoned that estab-
lishing its efficacy in this respect should be preliminary 
to investigating any clinical endpoint. Moreover, the vol-
ume of secretions in the ETT was an endpoint which we 
could assess with high precision, as previously described 
by our group using a novel technique such as MicroCT 
scan [8]. MicroCT, in comparison with other techniques 
proposed for the measurement of the amount of secre-
tions within the ETT, allowed us to directly study a large 
portion of the ETT (20 cm) with a fairly high resolution 
(35 μm).
The device we used is not the first cleaning system 
based on the retraction of an inflated balloon. Other 
similar devices were studied in the past, and showed 
good effectiveness [13, 14]. However, those devices were 
designed with the sole purpose of cleaning the ETT, 
requiring patient disconnection from the ventilator cir-
cuit. The novelty of the device used in this study is that 
the cleaning system is embedded in a closed suction sys-
tem resembling the one commonly used in our ICU for 
tracheal suction in patients expected to be ventilated 
for several days. The advantage of using a closed system 
is that patient disconnection is not required to perform 
both suction and cleaning maneuvers, and positive pres-
sure is preserved in the airways. Moreover, airways con-
tamination is reduced, and some guidelines recommend 
the use of such systems [15–18]. Thus, the study device 
offered features similar to the standard of care in our 
ICU, with the added benefit of ETT cleaning.
The patients enrolled in the study were representative 
of a general ICU population, including both surgical and 
medical patients. The analyzed ETTs were similar in the 
two groups, both in terms of size (Table 1) and number 
of days they remained in place (median 5 days, Table 2). 
In the control group, we report a cross-sectional area 
reduction similar to data available in the literature [8, 19, 
20]. Despite the use of the cleaning device, the ETTs in 
the treatment group did not result completely free from 
secretions, for several reasons. First, the efficacy of the 
cleaning system might not be optimal in some patients, 
possibly due to different physical properties of the secre-
tions (i.e., density, adhesion to the plastic surface) and to 
the presence of an amount of biofilm which is difficult to 
remove [21]. Second, in some patients, more than three 
cleaning maneuvers might be needed to preserve patency 
of the ETT. Future studies might investigate if a different 
protocol based on patients’ needs (i.e., equal number of 
cleaning and suction maneuvers) is more effective. Third, 
we did not clean the ETT immediately before extubation, 
and some secretions might have gathered within the ETT 
after the last cleaning maneuver was performed or dur-
ing the extubation procedure. We decided not to perform 
a cleaning maneuver before extubation to have a better 
understanding of the effects of the cleaning device on 
ETT patency during a real ICU shift, rather than imme-
diately after cleaning, adding strength to our results.
As we previously showed, the tip side is the part where 
secretions tend to collect, both because of the proximity 
with trachea, where secretions gather, and because that 
ETT part is the more dependent when the patient lies in 
the semi-recumbent position. We showed that the lack 
Table 3 Patient clinical course during ICU stay
mCPIS modified clinical pulmonary infection score, WBC white blood cells, PCT procalcitonin, RX score number of involved quadrants (0–4), TV tidal volume, PEEP 
positive end-expiratory pressure, CPL compliance, Res resistance to airflow, CRP c-reactive protein
* p < 0.05 as compared to control group
Day 1 treatment Controls Day 2 treatment Controls Day 3 treatment Controls
mCPIS 3 (2–5) 3 (3–5) 3 (1–4) 3 (2–5) 3 (2–4) 3 (2–4)
PaO2/FiO2 ratio 240 ± 75 215 ± 80 250 ± 72 204 ± 74 226 ± 61 199 ± 76
Body temperature (°C) 37.0 (36.5–37.3) 37.1 (36.5–37.5) 37 (36.3–37.7) 37.0 (36.3–37.4) 37 (36.8–37.5) 37.1 (36.7–37.7)
WBC, n × 109/L 8.8 (6.4–14.5) 9.2 (7.5–14.6) 10 (6.2–16.2) 10.4 (7.6–14.6) 8.3 (3.3–12.6) 8.5 (7.4–12)
PCT, ng/ml 7.4 (2.1–20.8) 1.8 (0.6–27.6) 2.8 (0.5–11.1) 1.8 (0.4–13.1) 1.91 (0.39–12.91) 1.2 (0.3–7.3)
RX score, n fields 1 (1–2) 2 (1–3) 2 (1–2) 2 (1–3) 2 (1–3) 2 (1–3)
TV, mL 500 ± 110 470 ± 100 430 ± 60 400 ± 90 460 ± 80 475 ± 140
PEEP, cmH2O 8 (7–10) 10 (7–12) 8 (6–10) 9 (8–11) 8 (7–10) 9 (8–13)
CPL, mL/cmH2O 46 (34–60) 46 (35–61) 47 (30–66) 41 (33-50) 50 (35–64) 44 (30–51)
Res, cmH2O·L−1·s−1 9 (9–11) 13 (10–15) 9 (8–11)* 15 (13–15) 9 (8–9) 9 (9)
CRP 11.6 (7.1–29.9) 17.1 (7.5–32.4) 16.6 (6.6–25.7) 15.4 (8.8–22.6) 15.5 (8.9–31.3) 9.6 (6.7–22.5)
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of secretion in the proximal, visible part of the ETT does 
not exclude a relevant loss of cross-sectional area in the 
endotracheal portion, whose presence can be clinically 
disclosed only by bronchoscopy. We showed that the use 
of a cleaning device reduces the loss of internal diameter, 
and the preventive effect is particularly evident in the tip 
side. This finding is consistent with the finding of reduced 
airflow resistance associated with the use of the novel 
CSS.
We could not demonstrate any difference in ETT path-
ogen colonization between the treatment and the control 
groups, a finding previously reported with other ETT 
cleaning devices [7]. The cleaning balloon is designed to 
maintain ETT patency, but a thin layer of contaminated 
biofilm could remain on the ETT surface resulting in 
positive cultures when colonization is assessed by lavage 
of the entire ETT. Future studies might investigate if ETT 
colonization can be reduced by cleaning balloons of dif-
ferent shape or using moisturizing solution other than 
saline. However, we report a reduced amount of leuko-
cytes in ETT lavage fluids obtained from the treatment 
group. We might speculate that the use of a cleaning 
device results in a reduced inflammatory stimulation of 
the mucosa, reflected by a lower amount of leukocytes 
in the ETT biofilm, lower mucosal fragility and reduced 
production of secretions, leading to a lower need for suc-
tion and less mucosal injury. Such findings, if confirmed, 
might be clinically relevant because lower production of 
secretions can lead to lower risk of sudden ETT obstruc-
tion and lower increase of airways resistance due to loss 
of ETT patency.
Regarding the major clinical outcomes, the present 
study was neither aimed, nor powered to demonstrate 
differences in mortality, ICU ventilator free days or VAP/
VAE incidence. Similarly, we could not find any differ-
ence in mCPIS, a clinical score associated with presence 
of lung infection. A larger population is needed to inves-
tigate those outcomes, and is debatable if a single com-
ponent of ETT care, such as a cleaning catheter, is able 
to significantly impact the clinical course of critically ill 
patients. Based on the results of this study, the use of a 
cleaning catheter appears safe and no relevant contrain-
dication to its use emerged. However, the relevance of 
the endpoints investigated in this study is not sufficient 
to mandate a change in the current practice and a routine 
use of such cleaning catheters in every intubated patient.
Conclusions
In this randomized clinical study, we report that the 
regular use of a cleaning CSS is effective in reducing the 
amount of secretions present in the ETT at extubation, 
particularly in the part closer to the trachea. The reduc-
tion of secretions in the ETT was associated with lower 
resistance to airflow in a subset of patients. We report no 
relevant adverse events related to the use of the clean-
ing device other than the ones known to be associated 
with standard suction. Studies on larger populations are 
needed to prove the relevance of the use of a cleaning 
catheter on major clinical outcomes.
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